Beckman Coulter achieves CE Mark for its MDW-SARS CoV-2 application as an aid in identifying patients with risk of COVID-19 in A&E

23 Mar 2022

Studies have shown that MDW is significantly higher in patients with COVID-19 than those without
Read More
Contact Beckman Coulter (UK) Ltd

Related Articles

Beckman Coulter’s DxI 9000 Analyser

Beckman Coulter unveils Immunoassay Analyser with No Daily Maintenance

Added: 15 May 2023

Beckman Coulter claims its DxI 9000 Access Immunoassay Analyser is the most productive immunoassay …

The MeMed BV test uses machine learning to integrate measurements of three key host-immune proteins

Beckman Coulter and MeMed Expand Access to Proven Host Immune Response Diagnostic

Added: 20 Feb 2023

Beckman Coulter Diagnostics has joined forces with MeMed, from the emerging field of advanced host-…

Beckman Coulter partners with smart4diagnostics to reduce the preanalytical data gap

Beckman Coulter partners with Smart4Diagnostics to close the data gap between blood collection and lab analysis

Added: 8 Aug 2022

Beckman Coulter has announced a partnership with German-based Smart4Diagnostics to close the preana…